Maythinee Chantadisai

Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results

Richard P. Baum, Christiane Schuchardt, Aviral Singh et al. · Journal of Nuclear Medicine · 2021 · 287 citations · Full text

MaligNet: Semisupervised Learning for Bone Lesion Instance Segmentation Using Bone Scintigraphy

Terapap Apiparakoon, Nutthaphol Rakratchatakul, Maythinee Chantadisai et al. · IEEE Access · 2020 · 45 citations · Full text

Convolutional Neural Network, Engineering, Machine Learning +18

Whole-body uptake classification and prostate cancer staging in 68Ga-PSMA-11 PET/CT using dual-tracer learning

Nicolò Capobianco, Ludovic Sibille, Maythinee Chantadisai et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 39 citations · Full text

Therapy-related myeloid neoplasm after peptide receptor radionuclide therapy (PRRT) in 1631 patients from our 20 years of experiences: prognostic parameters and overall survival

Maythinee Chantadisai, Harshad Kulkarni, Richard P. Baum · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 38 citations

Hematological Malignancy, Therapy-related Myeloid Neoplasm, Prognostic Parameters +13

Pretherapeutic Comparative Dosimetry of¹⁷⁷Lu-rhPSMA-7.3 and¹⁷⁷Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer

Benedikt Feuerecker, Maythinee Chantadisai, Anne Allmann et al. · Journal of Nuclear Medicine · 2021 · 30 citations · Full text